Company & Services
We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platforms are built on electrospinning and associated processing technologies. We are supporting clients with material development in a range of different therapeutic indications and territories, and supply electrospun biomaterial components into an FDA-approved medical device, the first such device to be sold in the USA.
We offer complete end-to-end services to take your product innovation through its development stages, from early feasibility to manufacturing. Our tried and tested processes allow swift progression from a development stage to a fully validated production process and manufacturing. Operating under ISO 13485 guidelines since 2015, we can provide the full suite of documentation for regulatory submissions worldwide. We will be your partners with a focus on downstream cost-of-goods, right from the beginning.
We are located in a purpose-built cleanroom facility on the Harwell Science and Innovation Campus, near Oxford, in the UK.
We are developing cell therapy tools including Kalyptix® immuno-protective technology, and the Symatix® membrane, a synthetic alternative to human amniotic membrane for use in wound healing and ophthalmology, and Coating technology, through direct deposition of the fibres onto the device we can achieve excellent encapsulation whilst our adhesion expertise ensures bonding of the electrospun textile to the frame.These technologies are available for collaborative development and licensing.